Literature DB >> 3881480

Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.

A Larsson, B Astedt.   

Abstract

Immunoreactive plasminogen activators were studied in tissue sections using a peroxidase method and monospecific antibodies to tissue plasminogen activator produced by a melanoma. Tissue plasminogen activator reactivity was found in skin melanomas and in endothelial and smooth muscle cells of arteries and veins. Vessels of the umbilical cord showed higher reactivity than peripheral vessels. Only faint antiurokinase reactivity was found. By means of the fibrin slide technique, fibrinolytic activity could be shown in peripheral vessel walls but not in the umbilical cord, which suggests that immunoreactivity of tissue plasminogen activator bound to an inhibitor can also be demonstrated. This method may be a useful tool in further studies of tissue plasminogen activator in physiological as well as pathological processes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881480      PMCID: PMC499093          DOI: 10.1136/jcp.38.2.140

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  30 in total

1.  Comparative studies on urokinase and plasminogen activator from cultured pancreatic carcinoma.

Authors:  M C Wu; A A Yunis
Journal:  Int J Biochem       Date:  1979

2.  Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells.

Authors:  M Wu; G K Arimura; A A Yunis
Journal:  Biochemistry       Date:  1977-05-03       Impact factor: 3.162

3.  An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture.

Authors:  L Holmberg; I Lecander; B Persson; B Astedt
Journal:  Biochim Biophys Acta       Date:  1978-11-15

4.  Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.

Authors:  D J Loskutoff; T E Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

5.  Plasminogen activators in ovarian tumours.

Authors:  L Svanberg; F Linell; M Pandolfi; B Astedt
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-03

6.  Purification of urokinase by affinity chromatography.

Authors:  L Holmberg; B Bladh; B Astedt
Journal:  Biochim Biophys Acta       Date:  1976-08-12

7.  Time-related release of various molecular forms of urokinase in tissue culture.

Authors:  B Astedt; G Barlow; L Holmberg
Journal:  Thromb Res       Date:  1977-08       Impact factor: 3.944

8.  On release and synthesis of fibrinolytic activators in human organ culture.

Authors:  B Astedt; M Pandolfi
Journal:  Rev Eur Etud Clin Biol       Date:  1972-03

9.  Relationship between tissue plasminogen activator and the activators in blood and vascular wall.

Authors:  D C Rijken; G Wijngaards; J Welbergen
Journal:  Thromb Res       Date:  1980-06-15       Impact factor: 3.944

10.  Immunological quantitation and immunoadsorption of urokinase-like plasminogen activators secreted by human cells.

Authors:  D Vetterlein; T E Bell; P L Young; R Roblin
Journal:  J Biol Chem       Date:  1980-04-25       Impact factor: 5.157

View more
  4 in total

1.  Tissue-type plasminogen activator in rat adrenal medulla.

Authors:  P Kristensen; D M Hougaard; L S Nielsen; K Danø
Journal:  Histochemistry       Date:  1986

2.  Plasminogen activators in human colorectal neoplasia.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

3.  Localization of tissue plasminogen activator in the endothelium of a limited number of vessels.

Authors:  E G Levin; G J del Zoppo
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

4.  Beta-amyloidolysis and glutathione in Alzheimer's disease.

Authors:  J Lasierra-Cirujeda; P Coronel; Mj Aza; M Gimeno
Journal:  J Blood Med       Date:  2013-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.